The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An examination of crizotinib activity in human tumor primary culture micro-spheroids isolated from patients with advanced non-small cell lung cancer.
Robert Alan Nagourney
Employment or Leadership Position - Rational Therapeutics
Stock Ownership - Rational Therapeutics
Sai-Hong Ignatius Ou
Employment or Leadership Position - Unitersity of California, Irvine
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
Paula J Bernard
Employment or Leadership Position - Rational Therapeutics
Federico R Francisco
Employment or Leadership Position - Rational Therapeutics
Steven S Evans
Employment or Leadership Position - Rational Therapeutics